ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Exploring the Potential Targets and Mechanisms of Huang Lian Jie Du Decoction in the Treatment of Coronavirus Disease 2019 Based on Network Pharmacology

Liu, Wang; Zeng, Yu; Li, Yanda; Li, Nanhong; Peng, Min; Cheng, Junfen; Tian, Binbin*; Chen, Mingdi*广东医学院; 南方医科大学
International Journal of General Medicine2021DOI: 10.2147/IJGM.S337025
6被引18阅读
引用收藏
分享

摘要

Background: In December 2019, coronavirus disease 2019 (COVID-19) caused by a novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2; previously known as 2019-nCoV) emerged in Wuhan, China, and caused many infections and deaths. At present, there are no specific drugs for the etiology and treatment of COVID-19. A combination of traditional Chinese and western medicine is proposed to treat COVID-19, in which Huang Lian Jie Du decoction (HLJDD) is recommended for the treatment of COVID-19 in many provinces in China and has been widely used in the clinic. This study explored the potential targets of HLJDD in the treatment of COVID-19 based on network pharmacology. @@@ Methods: First, the chemical composition and targets of HLJDD and COVID-19-related targets were obtained through the TCMSP, UniProt, GeneCards and OMIM databases. Second, HLJDD target and HLJDD-COVID-19 target networks were constructed via the STRING database and Cytoscape software. Finally, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of the HLJDD-COVID-19 targets was applied via the DAVID database. @@@ Results: Our study identified a total of 67 active ingredients of HLJDD and 204 targets of HLJDD. A total of 502 COVID-19-related targets were obtained, of which 47 were intersecting targets of HLJDD and COVID-19. A total of 179 GO terms and 77 KEGG terms, including the TNF signaling pathway, NF-kappa B signaling pathway and HIF-1 signaling pathway, were identified. @@@ Conclusion: The present study explored the potential targets and signaling pathways of HLJDD during the treatment of COVID-19, which may provide a basis for the research and development of drugs for the treatment of COVID-19.

学科与关键词

关键词
Huang Lian Jie Du decoctioncoronavirus disease 2019COVID-19SARS-CoV-2network pharmacologytraditional Chinese medicine
相关
加载中…
  • Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis
    Li, Xing; Wei, Shizhang; Niu, Shengqi; Ma, Xiao; Li, Haotian; Jing, Manyi; Zhao, Yanling*Computers in Biology and Medicine, 2022, 144: 105389.被引 106
  • Exploration of the Mechanism of Lianhua Qingwen in Treating Influenza Virus Pneumonia and New Coronavirus Pneumonia with the Concept of "Different Diseases with the Same Treatment" Based on Network Pharmacology
    Su, Huihui*; Wu, Guosong; Zhan, Lulu; Xu, Fei; Qian, Huiqin; Li, Yanling; Zhu, Ximei*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 5536266.被引 7
  • Integrated network pharmacology analysis and in vitro validation revealed the underlying mechanism of Xiyanping injection in treating coronavirus disease 2019
    Li, Jialin; Guo, Siyu; Tan, Yingying; Zhang, Jingyuan; Wu, Zhishan; Stalin, Antony; Zhang, Fanqin; Huang, Zhihong; Wu, Chao; Liu, Xinkui; Huang, Jiaqi; Wu, Jiarui*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(34): e34866.
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of General Medicine
发表日期
2021
卷期
第 14 卷
页码
9873-9885
DOI
10.2147/IJGM.S337025
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
2021 Zhanjiang Science and Technology Development Special Fund Competitive Allocation Project (High-level Hospital Construction Special Project of the Second Affiliated Hospital of Guangdong Medical University) [2021A05107]

作者

  • L

    Liu, Wang (第一作者)

    2 · guangdong med univ

  • Z

    Zeng, Yu

    2 · guangdong med univ

查看全部 8 位作者收起作者
  • L

    Li, Yanda

  • L

    Li, Nanhong

    southern med univ

  • P

    Peng, Min

    2 · guangdong med univ

  • C

    Cheng, Junfen

    2 · guangdong med univ

  • T

    Tian, Binbin (通讯)

  • C

    Chen, Mingdi (通讯)

    2 · guangdong med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417